시장보고서

상품코드

1605865

공간 유전체학과 전사체학 시장 규모, 점유율, 동향, 산업 분석 리포트 : 기술별, 제품별, 용도별, 최종사용자별, 지역별 : 시장 예측(2025-2034년)

Spatial Genomics & Transcriptomics Market Size, Share, Trends, Industry Analysis Report: By Technique, Product (Instrument, Consumables, and Software), Application, End User, and Region; Market Forecast, 2025 - 2034

발행일: 2024년 11월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 공간 유전체학과 전사체학 시장은 2034년까지 23억 9,932만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학에 대한 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.

공간유전체학 및 전사체학 시장은 맞춤형 의료에 대한 수요 증가와 복잡한 질병, 특히 암에 대한 높은 수준의 이해가 필요함에 따라 생의학 연구의 중요한 분야로 부상하고 있습니다. 공간 유전체학은 조직 구조의 공간적 맥락에서 유전자 발현을 매핑하는 데 사용되는 기술을 말합니다. 반면, 공간 전사체학은 특히 조직 샘플내 RNA의 국소화에 초점을 맞추었습니다. 이는 분자생물학과 조직학을 연결하여 연구자들이 원래의 환경에서 세포 컴포넌트 간의 복잡한 관계를 파악할 수 있게 해줍니다.

암 발병률 증가는 세포치료와 유전자 치료 연구를 더욱 촉진하고 있으며, 그 결과 공간 유전체학 및 전사체학 시장에 대한 대규모 투자가 이루어지고 있습니다. 세계보건기구(WHO)의 보고서에 따르면 2050년까지 3,500만 명 이상의 암 환자가 등록될 것으로 예상되며, 이는 2022년 대비 77% 증가한 수치입니다.

공간유전체학 및 전사체학의 응용 범위는 신경질환, 심혈관질환, 자가면역질환 등 다양한 질병에 적용됩니다. 예를 들어 신경생물학에서는 뇌 조직에서 유전자 발현의 공간적 분포를 이해함으로써 알츠하이머병, 파킨슨병과 같은 신경 퇴행성 질환의 근본적인 메커니즘을 이해할 수 있습니다. 이에 제약사 및 연구기관들은 이러한 복잡한 병태생리에 효과적으로 대처할 수 있는 표적 치료제를 개발하기 위해 공간유전체학 기술에 많은 투자를 하고 있습니다.

공간유전체학 및 전사체학 시장 보고서 하이라이트

공간유전체학 분야는 복잡한 질병, 특히 암을 이해하는 데 중요한 역할을 하므로 예측 기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.

2024년 공간 전사체학 분야는 공간 정보를 유지하면서 세포 수준에서 유전자 발현에 대한 풍부한 정보를 제공하는 능력으로 인해 공간 유전체학 및 전사체학 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.

번역 연구 분야는 실험실에서의 발견과 임상 적용 사이의 간극을 메우는 데 중요한 역할을 하므로 2024년 시장에서 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.

아시아태평양은 헬스케어 및 생명공학을 강화하기 위한 정부 구상과 유전체학 및 전사체학 능력의 빠른 발전으로 인해 예측 기간 중 가장 빠른 성장을 기록할 것으로 예상됩니다.

시장 스냅숏
공간 유전체학과 전사체학 시장 역학
- 촉진요인과 기회
  - 암이환율의 상승이 공간 유전체학 및 전사체학 시장을 촉진하고 있다.
  - 제4세대 시퀀싱의 도입으로 공간 유전체학과 전사체학 시장이 추진되고 있다.
- 억제요인과 과제
  - 고비용 및 복잡한 데이터 분석이 세계 시장을 방해하고 있다.
PESTEL 분석
공간 유전체학과 전사체학 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 공간 유전체학과 전사체학 시장 : 기술별

주요 조사 결과
서론
공간 유전체학
공간 전사체학

제6장 세계의 공간 유전체학과 전사체학 시장 : 제품별

주요 조사 결과
서론
기기
소모품
소프트웨어

제7장 세계의 공간 유전체학과 전사체학 시장 : 용도별

주요 조사 결과
서론
Translational 조사
Drug Discovery와 개발

제8장 세계의 공간 유전체학과 전사체학 시장 : 최종사용자별

주요 조사 결과
서론
학술 조사기관
계약 조사기관
제약·바이오테크놀러지 기업

제9장 세계의 공간 유전체학과 전사체학 시장 : 지역별

주요 조사 결과
서론
- 공간 유전체학과 전사체학 시장 평가 : 지역별, 2020-2034년
북미
- 북미 : 기술별, 2020-2034년
- 북미 : 제품별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 기술별, 2020-2034년
- 유럽 : 제품별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 기술별, 2020-2034년
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 기술별, 2020-2034년
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 기술별, 2020-2034년
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제11장 기업 개요

10X Genomics
Akoya Biosciences, Inc.
Bio-Rad Laboratories
Bio-Techne Corporation
BioSpyder Technologies Inc.
Cantata Bio
Danaher Corporation
Genomic Vision SA
Illumina
Lunaphore Technologies SA
Miltenyi Biotec
NanoString Technologies, Inc.
Natera, Inc.
Optical Biosystems Inc.

KSA 24.12.18

The global spatial genomics & transcriptomics market size is expected to reach USD 2,399.32 million by 2034, according to a new study by Polaris Market Research. The report "Spatial Genomics & Transcriptomics Market Size, Share, Trends, Industry Analysis Report: By Technique, Product (Instrument, Consumables, and Software), Application, End User, and Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The spatial genomics and transcriptomics market has emerged as a critical frontier in biomedical research, driven by the increasing demand for personalized medicine and the need for advanced understanding of complex diseases, particularly cancer. Spatial genomics refers to the techniques used to map gene expression within the spatial context of tissue architecture. In contrast, spatial transcriptomics focuses specifically on the localization of RNA within tissue samples. This bridges molecular biology and histology, allowing researchers to capture the intricate relationships between cellular components in their native environments.

Increasing cancer incidence is further fostering research on cell and gene therapies, which in turn is creating significant investments in the spatial genomics and transcriptomics market. As per the World Health Organization report, more than 35 million cases are expected to be registered by 2050, which is a rise of 77% from 2022.

The applications of spatial genomics and transcriptomics extend to a wide range of diseases, including neurological disorders, cardiovascular diseases, and autoimmune conditions. For instance, in neurobiology, understanding the spatial distribution of gene expression in brain tissues can uncover the mechanisms underlying neurodegenerative diseases such as Alzheimer's and Parkinson's. This has prompted pharmaceutical companies and research institutions to invest heavily in spatial genomics technologies as they seek to develop targeted therapies that effectively address these complex conditions.

Spatial Genomics & Transcriptomics Market Report Highlights

The spatial genomics segment is anticipated to witness the highest growth over the forecast period due to its critical role in understanding complex diseases, particularly cancer.

In 2024, the spatial transcriptomics segment accounted for the largest spatial genomics & transcriptomics market share, owing to its ability to provide rich information about gene expression at a cellular level while retaining spatial information.

The translational research segment accounted for the largest revenue share in the market in 2024 due to its crucial role in bridging the gap between laboratory discoveries and clinical applications.

APAC is projected to register the fastest growth over the forecast period due to rapidly advancing capabilities in genomics and transcriptomics, supported by substantial government initiatives aimed at enhancing healthcare and biotechnology.

The global players include 10X Genomics; Akoya Biosciences, Inc.; Bio-Rad Laboratories; Bio-Techne Corporation; BioSpyder Technologies Inc.; Cantata Bio; Danaher Corporation; Genomic Vision SA; Illumina; Lunaphore Technologies SA; Miltenyi Biotec; NanoString Technologies, Inc.; Natera, Inc.; and Optical Biosystems Inc.

Polaris Market Research has segmented the spatial genomics & transcriptomics market report based on technique, product, application, end user, and region:

By Technique Outlook (Revenue, USD Million, 2020 - 2034)

Spatial Genomics
Immunohistochemistry (IHC)
In Situ Hybridization
Sequencing Techniques
Microscopy-based RNA imaging
Other Spatial Genomics Techniques
Spatial Transcriptomics
Immunohistochemistry (IHC)
In Situ Hybridization
Sequencing Techniques
Other Spatial Transcriptomics Techniques

By Product Outlook (Revenue, USD Million, 2020 - 2034)

Instruments
Consumables
Software

By Application Outlook (Revenue, USD Million, 2020 - 2034)

Translational Research
Drug Discovery and Development

By End User Outlook (Revenue, USD Million, 2020 - 2034)

Academic Research Institutes
Contract Research Organizations
Pharmaceutical and Biotechnology Companies

By Region Outlook (Revenue, USD Million, 2020 - 2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Techniques
- 3.2.1. Primary Techniques
- 3.2.2. Secondary Techniques

4. Global Spatial Genomics & Transcriptomics Market Insights

4.1. Spatial Genomics & Transcriptomics Market - Market Snapshot
4.2. Spatial Genomics & Transcriptomics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising prevalence of cancer is driving the spatial genomics & transcriptomics market.
  - 4.2.1.2. Introduction of the fourth generation of sequencing is propelling the spatial genomics & transcriptomics market.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High costs and complex data analysis are hampering the global market.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Spatial Genomics & Transcriptomics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Spatial Genomics & Transcriptomics Market, by Technique

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
5.3. Spatial Genomics
- 5.3.1. Global Spatial Genomics & Transcriptomics Market, by Spatial Genomics, by Region, 2020-2034 (USD Million)
  - 5.3.1.1. Immunohistochemistry (IHC)
  - 5.3.1.1.1. Global Spatial Genomics & Transcriptomics Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Million)
  - 5.3.1.2. In Situ Hybridization
  - 5.3.1.2.1. Global Spatial Genomics & Transcriptomics Market, by In Situ Hybridization, by Region, 2020-2034 (USD Million)
  - 5.3.1.3. Sequencing Techniques
  - 5.3.1.3.1. Global Spatial Genomics & Transcriptomics Market, by Sequencing Techniques, by Region, 2020-2034 (USD Million)
  - 5.3.1.4. Microscopy based RNA imaging
  - 5.3.1.4.1. Global Spatial Genomics & Transcriptomics Market, by Microscopy based RNA imaging, by Region, 2020-2034 (USD Million)
  - 5.3.1.5. Other Spatial Transcriptomics Techniques
  - 5.3.1.5.1. Global Spatial Genomics & Transcriptomics Market, by Other Spatial Genomics Techniques, by Region, 2020-2034 (USD Million)
5.4. Spatial Transcriptomics
- 5.4.1. Global Spatial Genomics & Transcriptomics Market, by Spatial Transcriptomics, by Region, 2020-2034 (USD Million)
  - 5.4.1.1. Immunohistochemistry (IHC)
  - 5.4.1.1.1. Global Spatial Genomics & Transcriptomics Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Million)
  - 5.4.1.2. In Situ Hybridization
  - 5.4.1.2.1. Global Spatial Genomics & Transcriptomics Market, by In Situ Hybridization, by Region, 2020-2034 (USD Million)
  - 5.4.1.3. Sequencing Techniques
  - 5.4.1.3.1. Global Spatial Genomics & Transcriptomics Market, by Sequencing Techniques, by Region, 2020-2034 (USD Million)
  - 5.4.1.4. Other Spatial Transcriptomics Techniques
  - 5.4.1.4.1. Global Spatial Genomics & Transcriptomics Market, by Other Spatial Transcriptomics Techniques, by Region, 2020-2034 (USD Million)

6. Global Spatial Genomics & Transcriptomics Market, by Product

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
6.3. Instruments
- 6.3.1. Global Spatial Genomics & Transcriptomics Market, by Instruments, by Region, 2020-2034 (USD Million)
6.4. Consumables
- 6.4.1. Global Spatial Genomics & Transcriptomics Market, by Consumables, by Region, 2020-2034 (USD Million)
6.5. Software
- 6.5.1. Global Spatial Genomics & Transcriptomics Market, by Software, by Region, 2020-2034 (USD Million)

7. Global Spatial Genomics & Transcriptomics Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
7.3. Translational Research
- 7.3.1. Global Spatial Genomics & Transcriptomics Market, by Translational Research, by Region, 2020-2034 (USD Million)
7.4. Drug Discovery and Development
- 7.4.1. Global Spatial Genomics & Transcriptomics Market, by Drug Discovery and Development, by Region, 2020-2034 (USD Million)

8. Global Spatial Genomics & Transcriptomics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
8.3. Academic Research Institutes
- 8.3.1. Global Spatial Genomics & Transcriptomics Market, by Academic Research Institutes, by Region, 2020-2034 (USD Million)
8.4. Contract Research Organizations
- 8.4.1. Global Spatial Genomics & Transcriptomics Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
8.5. Pharmaceutical and Biotechnology Companies
- 8.5.1. Global Spatial Genomics & Transcriptomics Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Million)

9. Global Spatial Genomics & Transcriptomics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Spatial Genomics & Transcriptomics Market Assessment, By Geography, 2020-2034 (USD Million)
9.3. Spatial Genomics & Transcriptomics Market - North America
- 9.3.1. North America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.3.2. North America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.3.3. North America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.3.4. North America: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.3.5. Spatial Genomics & Transcriptomics Market - US
  - 9.3.5.1. US: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.3.5.2. US: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.3.5.3. US: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.3.5.4. US: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.3.6. Spatial Genomics & Transcriptomics Market - Canada
  - 9.3.6.1. Canada: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.4. Spatial Genomics & Transcriptomics Market - Europe
- 9.4.1. Europe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.4.2. Europe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.4.3. Europe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.4.4. Europe: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.5. Spatial Genomics & Transcriptomics Market - UK
  - 9.4.5.1. UK: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.5.2. UK: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.5.3. UK: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.5.4. UK: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.6. Spatial Genomics & Transcriptomics Market - France
  - 9.4.6.1. France: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.6.2. France: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.6.3. France: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.6.4. France: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.7. Spatial Genomics & Transcriptomics Market - Germany
  - 9.4.7.1. Germany: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.8. Spatial Genomics & Transcriptomics Market - Italy
  - 9.4.8.1. Italy: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.9. Spatial Genomics & Transcriptomics Market - Spain
  - 9.4.9.1. Spain: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.10. Spatial Genomics & Transcriptomics Market - Netherlands
  - 9.4.10.1. Netherlands: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.11. Spatial Genomics & Transcriptomics Market - Russia
  - 9.4.11.1. Russia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.12. Spatial Genomics & Transcriptomics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.5. Spatial Genomics & Transcriptomics Market - Asia Pacific
- 9.5.1. Asia Pacific: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.5. Spatial Genomics & Transcriptomics Market - China
  - 9.5.5.1. China: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.5.2. China: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.5.3. China: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.5.4. China: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.6. Spatial Genomics & Transcriptomics Market - India
  - 9.5.6.1. India: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.6.2. India: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.6.3. India: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.6.4. India: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.7. Spatial Genomics & Transcriptomics Market - Malaysia
  - 9.5.7.1. Malaysia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.8. Spatial Genomics & Transcriptomics Market - Japan
  - 9.5.8.1. Japan: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.9. Spatial Genomics & Transcriptomics Market - Indonesia
  - 9.5.9.1. Indonesia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.10. Spatial Genomics & Transcriptomics Market - South Korea
  - 9.5.10.1. South Korea: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.11. Spatial Genomics & Transcriptomics Market - Australia
  - 9.5.11.1. Australia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.12. Spatial Genomics & Transcriptomics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.6. Spatial Genomics & Transcriptomics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.5. Spatial Genomics & Transcriptomics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.6. Spatial Genomics & Transcriptomics Market - UAE
  - 9.6.6.1. UAE: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.7. Spatial Genomics & Transcriptomics Market - Israel
  - 9.6.7.1. Israel: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.8. Spatial Genomics & Transcriptomics Market - South Africa
  - 9.6.8.1. South Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.9. Spatial Genomics & Transcriptomics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.7. Spatial Genomics & Transcriptomics Market - Latin America
- 9.7.1. Latin America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.7.2. Latin America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.7.3. Latin America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.7.4. Latin America: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.5. Spatial Genomics & Transcriptomics Market - Mexico
  - 9.7.5.1. Mexico: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.6. Spatial Genomics & Transcriptomics Market - Brazil
  - 9.7.6.1. Brazil: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.7. Spatial Genomics & Transcriptomics Market - Argentina
  - 9.7.7.1. Argentina: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.8. Spatial Genomics & Transcriptomics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. 10X Genomics
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Akoya Biosciences, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bio-Rad Laboratories
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Bio-Techne Corporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. BioSpyder Technologies Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Cantata Bio
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Danaher Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Genomic Vision SA
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Illumina
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Lunaphore Technologies SA
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Miltenyi Biotec
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. NanoString Technologies, Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Natera, Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Optical Biosystems Inc.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development